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ABSTRACT
Studies on antioxidants as neuroprotective agents have been hampered by the impermeability of the blood brain
barrier (BBB) to many compounds. However, previous studies have shown that a group of tea (Camellia
sinensis) flavonoids, the catechins, are brain permeable and neuroprotective. Despite this remarkable observation,
there exists no data on the bioavailability and pharmacological benefits of tea anthocyanins (ACNs) in the brain
tissue.  This study investigated the ability of Kenyan purple tea ACNs to cross the BBB and boost the brain
antioxidant capacity. Mice were orally administered with purified and characterised Kenyan purple tea ACNs or
a combination of Kenyan purple tea ACN’s and coenzyme-Q
10
, at a dose of 200 mg kg-1 body weight in an
experiment that lasted for 15 days. Twenty four hours post the last dosage of antioxidants, CO
2
 was used to
euthenise the mice. Then the brain was excised and used for various biochemical analyses. Kenyan purple tea
ACNs significantly (P<0.05) raised brain Glutathione (GSH) levels, implying a boost in brain antioxidant
capacity. Notably, ACN metabolites were detected in brain tissue of ACN fed mice. This is the first demonstration
that Kenyan purple tea ACNs can cross the BBB, reinforcing the brain’s antioxidant capacity. Hence, there is
need to study ACNs as suitable candidates for dietary supplements that could support antioxidant capacity in
the brain and have potential to provide neuroprotection in neurodegenerative conditions.




Les études sur les antioxydants comme agents neuroprotecteurs ont été handicapées par l’imperméabilité de la
barrière de sang du cerveau (BBB) à plusieurs produits. Par ailleurs, les études antérieurs ont montré qu’un
groupe de flavonoïdes du thé (Camellia sinensis) , les catéchines, permettent la perméabilité du cerveau et
protègent les nerfs. Malgré cette observation importante, il n’ya pas de données sur la biodisponibilité et les
vertus pharmacologiques des anthocyanines du thé (ACNs) dans le tissue du cerveau. Cette étude a évalué
l’aptitude des anthocyanines du thé pourpre du Kenya  de traverser le BBB et améliorer la capacité antioxydante
du cerveau. Des rats étaient oralement administrés des anthocianines du thé pourpre  purifiés et caractérisés ou
une combinaison des  ACNs avec le coenzyme-Q
10
, à une dose de 200 mg kg-1 de poids vif  dans un essai d’une
durée de 15 jours. Vingt quatre heures après le dernier dosage d’antioxydants, le CO
2
 était utilisé pour euthanasier
les rats. Ensuite, le cerveau était excisé et soumis à  diverses analyses biochimiques. Les  ACNs ont  augmenté
significativement (P<0.05) les niveaux  du  Glutathione (GSH) du cerveau,,ce qui implique  une amélioration de
la capacité antioxydante du cerveau. Remarquablement, les métabolites ACN étaient détectés dans le tissu des
rats nourris aux ACNs. Ceci est la première démonstration que les anthocyanines (ACNs) du thé pourpre Kenyan
peuvent franchir la barrière hémato-encéphalique (BHE), renforçant ainsi la capacité antioxydante du cerveau.
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Ainsi, le besoin s’impose de les étudier comme des candidats appropriés pour les aliments de supplément qui
pourraient renforcer la capacité antioxydante dans le cerveau et avoir le potentiel d’offrir la neuroprotection dans
les conditions neurodégénératrices.




Tea (Camellia sinensis), an evergreen plant
native to China, is one of the most commonly
consumed beverages in the world; processed
from the young tender leaves of the plant (Cabrera
et al., 2003). The chemical composition of tea is
complex but includes polyphenols, amino acids,
carbohydrates, proteins, chlorophyll, volatile
compounds, minerals, trace elements and
alkaloids such as caffeine, theophylline and
theobromine. Among these, polyphenols
constitute the main bioactive molecules in tea
(Cabrera et al., 2003).
For centuries, the Chinese have used tea
beverage to treat a myriad of diseases (Sharangi,
2009). This pharmacological value of tea heavily
relies on its antioxidative properties known to
surpass that of major antioxidants such as
vitamins C and E (Rice-Evans et al., 1995) and
other synthetic antioxidants such as butylated
hydroxyl anisole (BHA) and butylated
hydroxytoluene (BHT) (Chen and Wan, 1994). The
ability of tea to scavenge for free radicals is
associated with the possession of a phenolic
hydroxyl group attached to the flavan-3-ol
structure of these compounds (Amie et al., 2003).
However, the importance of polyphenols in
enhancing resistance to oxidative stress goes
beyond simple radical scavenging activity. It is
also due to amplified activity of most detoxifying
enzymes such as glutathione peroxidase (GPx)
and glutathione reductase (GR) (Mandel et al.,
2006). Indeed, as a result of their free radical
quenching strengths, tea polyphenols have
widely been credited with therapeutic action
against free radical mediated diseases (Amie et
al., 2003).
Over the last few years, numerous
epidemiological and clinical investigations have
aroused increased interests in the use of tea
polyphenols as neuroprotective agents. This is
because previous studies have shown
phytochemicals present in tea such as
epigallocatechin gallate (EGCG) and epicatechin
(EC) metabolites formed after oral ingestion of
EC by rats, can cross the blood brain barrier
protecting nerve cells from reactive oxygen
species (ROS)-induced cell death (Mandel et al.,
2006). Other neuroprotective properties
associated with tea polyphenols include
preventing loss of dopaminergic neurons and
preservation of striatal levels of dopamine,
decreased expression of neuronal nitric oxide
synthase (nNOS), inhibition of pro-apoptotic
genes and protection against beta-amyloid
induced neurotoxicity (Zaveri, 2006). This
strongly suggests that tea polyphenols have
potential application in the treatment of
neurodegenerative disorders such as Alzheimer’s
and Parkinson’s disease.
However, compared to other flavonoid groups
from tea such as the catechins, little is known
about the bioavailability and pharmacological
benefits of tea anthocyanins (ACN). This is,
despite the fact that anthocyanins from other
sources have been associated with a broad
spectrum of health benefits including
cardiovascular, neurological, urinary tract and
ocular protection, as well as anti-carcinogenic,
anti-diabetic, anti-aging, antioxidant and anti-
inflammatory properties (Bagchi et al., 2004).
It has been widely established that isolated
individual antioxidants do not explain the
observed health benefits of diets, implying that
interactions between antioxidants may yield
positive synergistic effects (Chu et al., 2002).
Indeed, synergistic effects of various ACNs have
been demonstrated in black-current and wine
grapes (Hosseini-Beheshti et al., 2012). Therefore,
the health benefits of a diet rich in phytochemicals
is attributed to the complex mixture of
phytochemicals present in it, an observation
which clearly suggests that to improve their
nutrition and health, consumers should take
antioxidants from diverse sources. However, only
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a very limited number of studies have investigated
combinations of purified ACN extracts with other
chemical components of food.
Intracellular synthesis that occurs in the inner
mitochondrial membrane via the mevalonate
pathway, is the major source of Co-Q
10
, although
small amounts can be obtained from the diet
(Mancuso et al., 2010). Co-Q
10
 is an essential
cofactor involved in mitochondrial oxidative
phosphorylation and when reduced, it is a
powerful antioxidant that prevents oxidative
damage by free radicals including oxidation of
lipids within the mitochondrial membrane
(Matthews et al., 1998). More importantly, Co-
Q
10
 crosses the BBB exerting a multitude of
neuroprotective effects in the brain and
protecting against pathophysiology associated
with neurodegenerative disorders (Matthews et
al., 1998), hence the inclusion of this nutraceutical
in this study.
This study aimed at evaluating the synergistic,
additive or antagonistic types of interactions








ubiquinone, is an endogenously synthesized
lipid, which shuttles electrons from complexes I
and II to complex III (ubiquinol cytochrome c
oxidase) of the electron transport chain.
MATERIALS   AND   METHODS
Tea samples.  Purple tea used to extract ACNs
was obtained from the Tea Research Foundation
of Kenya, Timbilil Estate in Kericho (latitude 0
o22'S, longitude 35o21'E, altitude 2180 m.a.s.l).
ACNs were extracted from the purple tea variety
TRFK 306. Young tender shoots comprising of
two leaves plus a bud were harvested, dried using
a microwave and pulverised with a grinder into
fine powder.
Extraction, purification and lyophilisation of
anthocyanins.  Extraction and purification of tea
ACNs were carried out as described elsewhere
(Kerio et al., 2012). Prior to the lyophilisation of
ACNs extract, methanol and formic acid were
removed using a rotary evaporator at 35ºC under
vacuum and the residue was reconstituted with
distilled water. Pre-freezing of the extract was
done before being placed on the drying accessory.
A 200 ml sample of the ACN extract was each
placed in dehydration flasks and rapidly frozen
by spinning the round bottom flasks in a dry ice-
acetone bath. Temperature and pressure of the
lyophiliser were allowed to reach appropriate
levels of -40 ºC and 100x10-3 M Bar, respectively
before freeze drying process was initiated.
Lyophilisation was done using a Modulyo freeze
dryer (Edwards, England) producing a free
flowing powder that was weighed and stored in
airtight containers at room temperature until use.
HPLC analysis of anthocyanins.  Qualitative and
quantitative analyses of the tea extract and
anthocyanin profiles of purple tea variety TRFK/
306 were carried out in triplicates by high
performance liquid chromatography (HPLC) as
described elsewhere (Kerio et al., 2012).
Experimental animals.   All experimental
protocols and procedures involving use of mice
as experimental animals adhered to rules and
regulations approved by Institutional  Animal
Care and Use Committee (IACUC) of  the
Trypanosomiasis Research Centre of Kenya
Agricultural Research Institute (KARI-TRC)
Muguga, Kenya and Egerton University as well
as the National Regulations of the Kenya
Veterinary Association. A total of 15, eight-week
old female adult healthy Swiss white mice,
weighing between 21-30 g, were obtained from
the TRC breeding colony and used in all
experiments. The animals were housed in
standard mice cages at a temperature of 21-28 oC.
They were provided with ad libitum access to
water and standard mice cubes (Unga Feeds Ltd
Kenya), with wood-chippings provided as
bedding material. All mice were treated with 0.02
ml of Ivermectin (Ivermectin®, Anupco, Suffolk,
England) injected subcutaneously to each mouse
to eradicate endoparasites and ectoparasites
infestation.
After two weeks of acclimatisation, the mice
were randomly selected and divided into two
groups of five animals each. Appropriate controls
were used for this experiment. Group one was
supplemented with Kenyan purple tea ACNs;
while group 2 was supplemented with a
combination of Kenyan purple tea ACNs and Co-
Q
10
 . Note that we did not have a group on Co-Q
10
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alone because the antioxidant abilities of Co-Q
10
are well known and this study was focused on
determining if Co-Q
10 
will boost the beneficial
effects of ACNs.
The test antioxidants were administered orally
at a dosage of 200 mg kg-1 body weight for
fourteen days, after every second day using a
gavage needle. Twenty four hours after the last
dosage of antioxidants; carbon dioxide was used
to euthanize the mice after which the brain was
excised, snap frozen in dry ice and stored in liquid
nitrogen until analysis.
Packed cell volume (PCV) and body weight.   At
one week interval, blood was taken from each
mouse by tail snip into 100 ìl microhaematocrit
capillary tubes for PCV determination (Woo et
al., 1970). After blood collection, the capillary
tubes were sealed with plasticin at one end and
centrifuged in a haematocrit centrifuge (Hawksley
H England) at 10,000 revolutions per minute
(RPM) for 5 minutes. PCV was then read using a
micro-haematocrit reader and expressed as a
percentage of the total blood volume. Body
weight of each mouse was determined every two
days using the analytical electronic balance
(Mettler PM34, DoltaRange®).
Brain sample preparation.  Snap-frozen whole
brains were homogenised on ice water (4 ºC) in
0.5ml of 0.25 M sucrose, 5 mM Hepes-Tris, pH
7.4, with protease inhibitor cocktail to a final
concentration of 10% (w/v). The homogenates
were aliquoted into 1.5 ml microfuge tubes to
avoid repeated freeze-thaw process and stored
in liquid nitrogen until analysis
Glutathione assay.  Glutathione assay was
performed as described in a previous experiment
(Rahman et al., 2007), with slight modifications.
A volume of 50 µl of brain homogenates were
mixed with 50 µl solution containing
sulphosalicylic acid (5% w/v) and 0.25 mM
ethylene diamine tetra-acetic acid (EDTA) and
the mixture centrifuged at 8000xg for 10 minutes
at 4 oC. A volume of 200 µmol l-1 of GSH standard
solution was prepared in 0.5% sulphosalicylic
acid (SSA) and serial dilutions made using the
same solution (0.5% SSA) to final concentrations
of 100, 50, 25, 12.5, 6.25, 3.13 and 1.56 µmol l-1.
Ellman’s reagent (5,5’-Dithiobis (2-nitrobenzoic
acid (DTNB)) was prepared by dissolving in 0.1
M potassium phosphate buffer with 5 mM EDTA
disodium salt, pH 7.5 (KPE buffer) to a final
concentration of 0.6 mg ml-1.  A volume of 25 µl of
each standard were loaded on a 96-well microtitre
plate to wells B–H in column 1, 2 and 3 followed
by 25 µl of the sample to the remaining wells in
triplicate. To each well, 100 µl of  freshly prepared
DTNB was then added and the absorbance
measured at 405nm at intervals of 30 seconds
using a multi-detection microtitre plate reader
(Bio-Tek Synergy HT).
HPLC for detection of anthocyanins.   A volume
of 600 µl methanol/formic acid (99/1) was mixed
with 600 µl brain homogenate in a 1.5 ml microfuge
tube and the mixture centrifuged at a speed of
5000 g for 10 minutes. One millilitre of the
supernatant was then pipetted into a separate
tube and HPLC analysis of the samples carried
out as described in the earlier section, “High-
performance liquid chromatography analysis of
anthocyanins”.
Data analysis. Data were analysed using Prism
Graph pad version 5.0 and at a P<0.05. Significance
of difference between means for PCV and
glutathione was determined by one way ANOVA
and Tukey post hoc test was performed to
evaluate differences among group means.
RESULTS
Purple tea anthocyanin profile.  Following
lyophilisation of the anthocyanin extracts, a free
flowing powder that was bright red in colour, with
a characteristic smell of fresh berries was
produced. ACN profiling of Kenyan purple tea
revealed presence of anthocyanidins; cyanidin,
peonidin, pelargonidin, delphinidin and malvidin
(Fig. 1). The anthocyanidins profile revealed
cyanidin as the most abundant (1755.60 µg ml);
while delphinidin was the least (122.85 µg ml-1)
abundant (Table 1).
Retention time
Anthocyanin in brain tissue.  ACN metabolites,
vividly absent from animals not supplemented
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Figure 1.   A representative HPLC chromatogram of un-aerated (green) tea from a Kenyan purple tea variety clone TRFK 306.
Tea anthocyanins and coenzyme-Q
10
 in mice
Clinical symptoms and survival. Animals
supplemented with ACNs and Co-Q
10 
were marked
with hyperactivity from the onset of Co-Q
10
supplementation to the last day of the experiment.
No clinical signs were detectable in the ACNs
only groups, signifying that the tea polyphenols
were well tolerated in the experimental animals.
One animal supplemented with both test
antioxidants died 9 days post start of antioxidant
administration.
Packed cell volume and body weight.  PCV levels
and body weight baseline data are presented in
Table 3. There was a gradual increase in PCV levels
of the untreated animals throughout the
experiment rising from 55.2± 0.49 to 58.4± 2.50%.
Experimental animals supplemented with ACNs
only and ACNs and Co-Q
10
 had a rather steady
TABLE  1.   Concentration of anthocyanins in non-aerated
(green) tea derived from Kenyan purple leaf colored variety
TRFK 306 by HPLC









Total anthocyanin content 3584.23




with ACNs and having very close retention times
to individual intact anthocyanins (Table 2), were
detected in brain tissue of animals from the various
anthocyanins groups (Fig.  2).
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TABLE  2.   Retention times in minutes of the detected metabolites against intact individual anthocyanins








Figure 2.   Representative HPLC chromatogram of brain homogenates from animal not supplemented with antioxidants (A), animal
supplemented with ACN’s and Co-Q
10
 (B) and animal supplemented with ACN’s only (C). Chromatograms B and C show
presence of possible ACN’s metabolites in the brain tissue indicated by arrows.
increase in PCV, rising from 53.4± 1.03 and 53.4±
1.36%, three days prior to antioxidant
administration to 58.6± 1.08 and 59.25± 2.03% on
the sixth day after the start of antioxidant
administration, respectively. This was followed
by a steady decrease in PCV levels to the last
day of the experiment, reaching 53.2± 1.93 and
55± 0.71% in ACNs only and ACNs and Co-Q
10
groups, respectively. However, these fluctuations
did not portray a statistical significant difference
(P>0.05) between the different groups analysed.
Mice receiving both antioxidants showed a
significant decrease in mean body weight
changes during the experimental period (P<0.05)
(Fig.  3). The decrease in weight commenced
immediately after the start of antioxidant
administration, falling from 26.76±0.77 to
23.30±1.67g by the seventh day post start of
antioxidant administration (DPSAA) after which
a marginal increase was observed reaching
23.45±1.82 g. Animals supplemented with ACNs
lost weight consistently from the first DPSAA to
the last day of the experiment, dropping from
27.88±1.60 to 25.76±1.69 g. Untreated animals
registered an unsteady, but gradual increase in
mean body weight rising from 24.64±0.59 to
26.3±0.50 g by the end of the experimental period.
However, no significant differences in mean body
Kenyan purple tea anthocyanins ability to cross the blood brain barrier 825
TABLE 3.   Changes in PCV levels of mice supplemented with ACNs, ACNs and Co-Q
10 
or water only
Days post start of antioxidant administration                                       PCV levels in %
Controls ACNs ACNs and Co-Q
10
-3 55.2 ±0.49 53.4±1.03 53.40±1.36
6 57.4±0.51 58.6±1.08 59.25±2.03
12 58.4±2.50 53.2±1.93 55.00±0.71
Figure 3.   Changes in body weight of mice supplemented with ACNs, ACNs and Co-Q
10
















Days post start of antioxidant administration




weight were recorded between untreated animals




levels.  The level of GSH in brain tissue of mice
supplemented with either one or both antioxidant
supplements is presented in Figure 4.
Supplementing experimental animals with Kenyan
purple tea ACNs significantly boosted the levels
of endogenous total GSH levels in the brain tissue
(2.22±0.18 µM) compared with the controls
(1.27±0.12 µM) (P=0.0006). However, when both
test antioxidants were provided, there was a
decline in total GSH levels to amounts below even
the level recorded in healthy animals not
supplemented with antioxidants (0.97± 0.06  µM).
DISCUSSION
Polyphenols and other phytochemicals in plants
must cross the BBB to be able to exert their
beneficial effects in the central nervous system
(CNS). Otherwise, the multitude of health benefits
associated with these flavonoids, such as strong
antioxidant and anti-inflammatory properties,
would be excluded from the brain and the CNS  in
general. Our research clearly demonstrates that
ACNs from the Kenyan purple tea cross the BBB
and exert physiological effects by boosting
antioxidant capacity in the brain. The presence
of ACNs in this pivotal organ was confirmed by
the detection of  ACN  metabolites in the ACN
fed animals. These metabolites were  absent in
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Figure 4.  Total brain GSH levels in mice supplemented with ACNs, ACNs and Co-Q
10
 or water only. #P<0.05, statistically






















the placebo group that was not fed the purple
tea. However, we were not able to detect intact
ACNs from the brain homogenates of the ACN
fed mice. Considering that approximately two-
thirds of ACNs are highly biotransformed and
end up as methylated and glucuronidated
metabolites (Kay, 2006), absence of such intact
ACN’s in the brain homogenates of our ACN fed
mice was not surprising.
Our results also indicate that oral intake of
tea ACNs markedly increases brain GSH levels.
Indeed, ACNs from a wide array of sources have
been shown in several instances to up-regulate
endogenous antioxidant levels. A previous study
working with the same variety of purple tea
reported an increase in cellular GSH content in
cells exposed to ACNs (Kerio et al., 2011). Red
mixed berry juice rich in ACNs has also been
shown to decrease oxidative DNA damage,
increase GSH levels and glutathione status in
healthy human volunteers (Weisel et al., 2006).
The mechanisms by which ACNs are thought to
exert these effects include quenching of ROS,
chelating of metals known to participate in
reactions that result in the vicious formation of
reactive moieties and by the activation of
antioxidant response element (ARE) upstream of
genes that are involved in antioxidation and
detoxification (Shih et al., 2007).
Our results on PCV, body weight and brain
glutathione strongly suggest negative
interactions between Kenyan purple tea ACNs
and Co-Q
10
.  An antagonistic effect between the
two antioxidants was unexpected as it was
thought that the nutraceuticals would have a more
pronounced synergistic effect in combination
rather than in isolation. However, ACNs and other
substances known to lower cholesterol levels or
prevent its absorption are expected to have
adverse effects on non sterol compounds such
as Co-Q
10
 (Bliznakov et al., 1998). The negative
interactions have also been observed while
employing other lipid lowering substances such
as HMG-CoA competitive inhibitors known as
statins (Bliznakov et al., 1998). Indeed, several
authors have reported the ability of Co-Q
10 
to
reverse the detrimental side effects associated
with statins including muscle myopathy and
rhabdomyolysis (Langsjoen and Langsjoen,
2003). Further studies will be necessary to
determine whether indeed purple tea ACNs could
nullify the beneficial effects of Co-Q
10
supplements or vice versa.
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CONCLUSION
Data from our study provide compelling evidence
that Kenyan purple tea ACNs are able to cross
the BBB and exert their physiological effects in
this organ by up-regulating endogenous
antioxidant reserves. We, therefore, recommend
the study of this nutraceutical as a suitable
candidate for consideration as dietary
supplements to modulate conditions associated
with oxidative stress in the brain such as
Alzheimer’s and Parkinson’s disease,
amyotrophic lateral sclerosis (ALS) and multiple
sclerosis.
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